Epigenetics predicts the efficacy of T-lymphocyte treatments in hematological malignancies
In the last few years, an alternative for these cases has emerged: a cell therapy known as CAR-T that collects the T-lymphocytes of these patients, modifies them through genetic engineering in the laboratory and administer ...
Oct 4, 2021
0
8